 |
|
Prospective Evaluation of Radiculitis following Bone Morphogenetic Protein-2 Use for Transforaminal Interbody Arthrodesis in Spine Surgery
Arjun S. Sebastian, Nathan R. Wanderman, Bradford L. Currier, Mark A. Pichelmann, Vickie M. Treder, Jeremy L. Fogelson, Michelle J. Clarke, Ahmad N. Nassr
Asian Spine J. 2019;13(4):544-555. Published online 2019 Mar 15 DOI: https://doi.org/10.31616/asj.2018.0277
|
|
Citations to this article as recorded by
 Comparative Study of Radiological and Clinical Outcomes in Patients Undergoing Minimally Invasive Lateral Lumbar Interbody Fusion Using Demineralized Bone Matrix Alone or with Low-Dose Escherichia coli–Derived rhBMP-2
Young-Ho Roh, Jae Chul Lee, Hyung-Ki Cho, Hae-Dong Jang, Sung-Woo Choi, Byung-Joon Shin
World Neurosurgery.2022; 158: e557. CrossRef Efficacy and safety of Escherichia coli-derived recombinant human bone morphogenetic protein-2 in additional lumbar posterolateral fusion: minimum 1-year follow-up
Hee Jung Son, Sung Hoon Choi, Myoung Keun Lee, Chang-Nam Kang
The Spine Journal.2021; 21(8): 1340. CrossRef Post-operative radiculitis following one or two level anterior lumbar surgery with or without posterior instrumentation
Matthew S. Griffith, K. Aaron Shaw, Brian K. Burke, Keith Lynn Jackson, David M. Gloystein
Journal of Orthopaedics.2021; 25: 45. CrossRef
|